A Multicenter Retrospective Study of Treatment Outcomes and Prognostic Factors for Stereotactic Radiofrequency Thermal Coagulation (RFTC) for Drug-Resistant Focal Epilepsy

A Multicenter Retrospective Study of Treatment Outcomes and Prognostic Factors for Stereotactic Radiofrequency Thermal Coagulation (RFTC) for Drug-Resistant Focal Epilepsy - A Multicenter Retrospective Study of Stereotactic Radiofrequency Thermal Coagulation (RFTC) for Drug-Resistant Epilepsy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057909

Enrollment

Registered

2025-05-20

Start date

2025-03-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-resistant epilepsy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of drug-resistant focal epilepsy 2. Patients how underwent stereotactic radiofrequency thermocoagulation for the treatment of drug-resistant focal epilepsy and had at least one-year postoperative follow-up 3. Aged 2 years or older, and younger than 70 years

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Seizure outcomes at one year after surgery	—

Secondary

Measure	Time frame
Seizure outcome at last follow-up, Surgery-related complications, Acute and chronic postoperative complications, Planned treatment area, Target volume, Resulting volume, Coagulation ratio, Number of ablations, Number of brain punctures, Etiology of epilepsy, Treatment sites	—

Countries

Japan

Contacts

Public ContactMasaki Iwasaki

National Center Hospital, National Center of Neurology and Psychiatry Neurosurgery

iwa@ncnp.go.jp+81-42-341-2711

Outcome results